Amgen Repurchases Astellas’ Stakes in Amgen Astellas JV to Strengthen its Footprints in Japan

Shots:

• Amgen has consummated the purchase of Astellas’49% shares of AABP, a JV between Amgen and Astellas established in 2013
• AABP now serves as a wholly-owned Amgen affiliate in Japan while the Amgen renamed it as Amgen KK, enabling the company to bolster its presence in Japan
• Amgen KK will continue the marketing of therapies targeting CV, cancer, osteoporosis and will bring Amgen’s global pipeline to Japanese patients. Additionally, in 2019, Amgen has invested ~$4B in research and development to advance new therapies across all stages of its pipeline

Click here ­to­ read full press release/ article | Ref: Amgen | Image: Behance